Top 20 of Liver Diseases

Article title # Publications/# Citations

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

2007: HBEl-Serag; KLRudolph;


Transection of the oesophagus for bleeding oesophageal varices.

1973: JLDawson; IMMurray-Lyon; MCPietroni; RNPugh; RWilliams;


CD4+ count-guided interruption of antiretroviral treatment.

2006: Strategies for Management of Antiretroviral Therapy (SMART) Study Group; DAbrams; RCArduino; ABabiker; WBurman; NClumeck; CJCohen; DCohn; ... DCooper; JDarbyshire; WMEl-Sadr; SEmery; GFätkenheuer; BGazzard; FGordin; BGrund; JHoy; KKlingman; MLosso; JLundgren; NMarkowitz; JDNeaton; JNeuhaus; APhillips; CRappoport;


Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

1995: DBaltimore; AABeg; RTBronson; SGhosh; WCSha;


Cloning of a new cytokine that induces IFN-gamma production by T cells.

1995: AHakura; KHattori; TKomatsu; YNukada; HOkamura; TOkura; TTanimoto; KTorigoe; HTsutsi; MYutsudo;


The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

1989: GEGrau; VKindler; PFPiguet; APSappino; PVassalli;


Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

2000: KPHoeflich; OJin; JLuo; EARubie; MSTsao; JRWoodgett;


Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

2008: SLFriedman;


Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

2006: GCFarrell; CZLarter;


Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.

2001 Dec 20-27: AOhta; MSitkovsky;


Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

2012: American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD); RMBergenstal; JBBuse; MDiamant; EFerrannini; SEInzucchi; DRMatthews; ... MNauck; ALPeters; ATsapas; RWender;


Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

2006 Aug 14-28: BAkerlund; GCalvo; FDabis; Sde Wit; WMEl-Sadr; NFriis-Møller; OKirk; MGLaw; ... BLedergerber; JDLundgren; AdMonforte; ANPhillips; CPradier; PReiss; MRickenbach; CASabin; RWeber;


Long-term follow-up of patients with NAFLD and elevated liver enzymes.

2006: GBodemar; MEkstedt; LEFranzén; MHolmqvist; SKechagias; ULMathiesen; LThorelius;


The enzymes, regulation, and genetics of bile acid synthesis.

2003: DWRussell;


Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

2008: JBean; JJBissler; ASBrody; GChuck; JMElwing; DNFranz; TLaor; JMLeonard; ... FXMcCormack; SSalisbury; VJSchmithorst; LRYoung;


Galactosamine-induced sensitization to the lethal effects of endotoxin.

1979: MAFreudenberg; CGalanos; WReutter;


Intravascular danger signals guide neutrophils to sites of sterile inflammation.

2010: PLBeck; SAHirota; PKubes; BMcDonald; GBMenezes; DAMuruve; KPittman; ISlaba; CCWaterhouse;


The natural history of hepatitis C virus infection: host, viral, and environmental factors.

2000: FAAnania; JAstemborski; JBoitnott; NGalai; LJohnson; OLaeyendecker; KENelson; KNolt; ... RMRai; MSchaeffer; SAStrathdee; DLThomas; DVlahov; LEWilson;


Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

1993: AKGroen; CAMol; ROttenhoff; RPOude Elferink; AHSchinkel; JJSmit; Lvan Deemter; NMvan der Lugt; MAvan Roon; EWagenaar;


Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

2002: LBen-Porat; LHBlumgart; CCorvera; RPDeMatteo; YFong; MGonen; WRJarnagin; SLittle; SWeber;